Who owns Ngm Biopharmaceuticals Inc?
- CUSIP Number: 62921n105
Tip: Access positions for across all investors
Analyze quarterly positions in Ngm Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ngm Biopharmaceuticals stock
Who bought or sold Ngm Biopharmaceuticals Inc this quarter?
There are no current stakeholders of Ngm Biopharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Ngm Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 3.0M | $4.8M |
| Vanguard Group | Mar 2024 | 2.3M | $3.7M |
| State Street Corporation | Mar 2024 | 823k | $1.3M |
| Two Sigma Advisers | Mar 2024 | 506k | $804k |
| Northern Trust | Mar 2024 | 373k | $593k |
| Balyasny Asset Management | Mar 2024 | 361k | $573k |
| Goldman Sachs Group | Mar 2024 | 209k | $333k |
| Morgan Stanley | Mar 2024 | 156k | $247k |
| Nuveen Asset Management | Mar 2024 | 94k | $150k |
| Alliancebernstein | Mar 2024 | 64k | $102k |
| Virtu Financial | Mar 2024 | 49k | $77k |
| Two Sigma Investments | Mar 2024 | 28k | $44k |
| Oxford Asset Management | Mar 2024 | 20k | $31k |
| Jasper Ridge Partners | Mar 2024 | 19k | $31k |
| Tower Research Capital | Mar 2024 | 3.7k | $5.8k |